Table 1

Patient characteristics of all enrolled cases

Number of cases (%)
AgeMean59.5
Range38–75
GenderMale24 (68.8)
Female11 (31.3)
HistologyAdenocarcinoma25 (71.4)
Squamous cell carcinoma8 (22.9)
Large cell carcinoma1 (2.9)
Atypical carcinoid1 (2.9)
Performance status03 (8.6)
132 (91.4)
Clinical stagingc-stage IIIB6 (17.1)
c-stage IV20 (57.1)
Recurrence9 (25.7)
EGFR mutation statusWild28 (80)
Mutation7 (20)
Prior treatmentPlatinum-based chemotherapy30 (85.7)
Gefitinib5 (14.3)
Surgery11 (31.4)
Radiation therapy11 (31.4)